Edgemond James sold 1,298 shares of UNITED THERAPEUTICS Corp at $549.06 for −$713k on Jun 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CFO AND TREASURER
CFO AND TREASURER
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$712,678.06Shares × reported price
Shares traded
1,298Common Stock
Price per share
$549.06Reported price. Read footnotes for ranges.
% of reported position traded
6.4%This security and ownership context
Holdings after
18,996Direct
Trade date
Jun 4, 2026Sell
Filed
Jun 5, 2026, 4:31 PM ET1-day reporting delay
Accession
0001636178-26-000024Code S · Transaction 100289
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 20,294 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 4, 2026Sell120$539.64−$64,756.72Trade 100281
Jun 4, 2026Sell480$541.14−$259,748.78Trade 100282
Jun 4, 2026Sell440$542.78−$238,821.84Trade 100283
Jun 4, 2026Sell1,086$544.11−$590,905.52Trade 100284
Jun 4, 2026Sell1,545$544.94−$841,938.79Trade 100285
Jun 4, 2026Sell1,129$545.89−$616,308.12Trade 100286
Jun 4, 2026Sell1,033$547.00−$565,054.62Trade 100287
Jun 4, 2026Sell2,749$548.04−$1,506,554.81Trade 100288
Jun 4, 2026Sell120$550.48−$66,057.20Trade 100290
Jun 4, 2026Option exercise10,000$0.00$0Trade 100291
Jun 4, 2026Option exercise10,000$117.76$1,177,600Trade 100280
12 transaction rows in this filing. Joint filers share the same rows.

UTHR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
UTHR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +4.1%1w ago +2.2%1d ago −0.1%
Returns since7d −0.7%30d +1.1%90d180d1y

Footnotes in full

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. F10: This transaction was executed in multiple trades at prices ranging from $548.55 to $549.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F11: This transaction was executed in multiple trades at prices ranging from $550.39 to $550.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: This transaction was executed in multiple trades at prices ranging from $539.29 to $540.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: This transaction was executed in multiple trades at prices ranging from $540.76 to $541.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4: This transaction was executed in multiple trades at prices ranging from $542.40 to $543.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5: This transaction was executed in multiple trades at prices ranging from $543.51 to $544.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6: This transaction was executed in multiple trades at prices ranging from $544.51 to $545.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7: This transaction was executed in multiple trades at prices ranging from $545.52 to $546.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F8: This transaction was executed in multiple trades at prices ranging from $546.52 to $547.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F9: This transaction was executed in multiple trades at prices ranging from $547.52 to $548.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.